Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) closed the day trading at $293.64 up 7.64% from the previous closing price of $272.79. In other words, the price has increased by $7.64 from its previous closing price. On the day, 0.86 million shares were traded. MDGL stock price reached its highest trading level at $301.44 during the session, while it also had its lowest trading level at $270.51.
Ratios:
For a better understanding of MDGL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.93 and its Current Ratio is at 5.98. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.
On June 11, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $382.
On April 22, 2024, BofA Securities started tracking the stock assigning a Underperform rating and target price of $150.BofA Securities initiated its Underperform rating on April 22, 2024, with a $150 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 17 ’25 when Kelley Shannon T sold 277 shares for $273.41 per share. The transaction valued at 75,735 led to the insider holds 7,705 shares of the business.
Waltermire Robert E. sold 442 shares of MDGL for $120,847 on Jan 17 ’25. The Senior VP, Chief Pharma Dev. now owns 5,058 shares after completing the transaction at $273.41 per share. On Jan 17 ’25, another insider, Taub Rebecca, who serves as the Pres., R&D, and CMO of the company, sold 1,689 shares for $273.41 each. As a result, the insider received 461,789 and left with 457,310 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDGL now has a Market Capitalization of 6404406272 and an Enterprise Value of 5524921856. For the stock, the TTM Price-to-Sale (P/S) ratio is 83.38 while its Price-to-Book (P/B) ratio in mrq is 8.24. Its current Enterprise Value per Revenue stands at 71.927 whereas that against EBITDA is -10.097.
Stock Price History:
The Beta on a monthly basis for MDGL is -0.38, which has changed by 0.25928462 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, MDGL has reached a high of $368.29, while it has fallen to a 52-week low of $168.25. The 50-Day Moving Average of the stock is -7.12%, while the 200-Day Moving Average is calculated to be 12.42%.
Shares Statistics:
Over the past 3-months, MDGL traded about 450.18K shares per day on average, while over the past 10 days, MDGL traded about 507430 shares per day. A total of 21.81M shares are outstanding, with a floating share count of 18.39M. Insiders hold about 15.70% of the company’s shares, while institutions hold 104.26% stake in the company. Shares short for MDGL as of 1735603200 were 4106529 with a Short Ratio of 9.12, compared to 1732838400 on 4281332. Therefore, it implies a Short% of Shares Outstanding of 4106529 and a Short% of Float of 27.02.
